Carpal tunnel syndrome (CTS). Carpal tunnel syndrome
Conditions
Interventions
Intervention 1: In the intervention group, rosuvastatin 20 mg once daily. Intervention 2: A daily control group is prescribed a placebo tablet for one month.
Treatment - Drugs
Placebo
In the intervention group, rosuvastatin 20 mg once daily.
A daily control group is prescribed a placebo tablet for one month
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
16 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criterion: Patients with mild to moderate clinical symptoms and electrodiagnostic features of CTS. Exclusion criteria: patients who have a history of taking statins; history of previous surgery for CTS; patients with severe CTS with muscle atrophy; extreme sensitivity to statins.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Median nerve motor and sensory distal latency. Timepoint: 1 month(interval between the onset of treatment determines the outcome of the study). Method of measurement: nerve conduction study.;Symptom severity and functional status of the patient. Timepoint: 1 month. Method of measurement: According to Boston Questionnaire.;Severity of pain. Timepoint: 1 month. Method of measurement: Visual Analogue Scale (VAS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Patients' function. Timepoint: 1. Method of measurement: Boston Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Poursadegh Fard
Shiraz University of Medical Sciences
Outcome results
None listed